Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.49 |
| ▸ | DPP4 | P27487 | 1/20 | 0.49 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.49 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
| ▸ | GRM8 | O00222 | 1/20 | 0.47 |
| ▸ | GRM6 | O15303 | 1/20 | 0.47 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.47 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL210006 | 0.95 | FOLH1 (0.62) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL15420941 | 0.95 | FOLH1 (0.62) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL15420942 | 0.95 | FOLH1 (0.62) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL210315 | 0.95 | FOLH1 (0.62) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL536354 | 0.95 | FOLH1 (0.62) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL27611015 | 0.92 | FOLH1 (0.58) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL16770243 | 0.92 | FOLH1 (0.58) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL27611010 | 0.92 | FOLH1 (0.58) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| Glycine SCHEMBL2793248 | 0.91 | ALOX15 (0.47) | FOLH1PTGS1GSTK1DPP4DPP8 | |
| SCHEMBL9760353 | 0.91 | FOLH1 (0.61) | FOLH1PTGS1GSTK1DPP4DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361860-A4 | MODULATED RELEASE PARTICLES FOR AEROSOL DELIVERY | KOS LIFE SCIENCES INC (US) | 2009-06-03 | — | — | EP | claimed |
| EP-1361860-A1 | MODULATED RELEASE PARTICLES FOR AEROSOL DELIVERY | Aeropharm Technology Incorporated (US) | 2003-11-19 | — | — | EP | claimed |
| WO-2002066011-A1 | MODULATED RELEASE PARTICLES FOR AEROSOL DELIVERY | AEROPHARM TECHNOLOGY, INC. (US) | 2002-08-29 | — | — | WO | claimed |
| WO-2002029416-A2 | METHOD FOR DETERMINING CHEMICAL REACTIVITY | PHARMACIA & UPJOHN COMPANY (US) | 2002-04-11 | — | — | WO | claimed |
| CN-117915891-A | Combination therapy for the treatment of liver diseases | 甘莱制药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-117915914-A | Combination therapy for treating liver diseases | 甘莱制药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-109884017-A | Based on ZGC and MnO2Detection of the fluorescent optical sensor of nanometer sheet to glutathione | 济南大学 | 2019-06-14 | — | — | CN | disclosed |
| US-20120012123-A1 | COMPOSITIONS, ARTICLES AND METHODS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2012-01-19 | — | — | US | disclosed |
| US-20100179133-A1 | COMPOSITIONS, ARTICLES AND METHODS COMRISING TSPO LIGANDS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2010-07-15 | — | — | US | disclosed |
| US-20100166833-A1 | Compositions, articles and methods for preventing or reducing tobacco-associated damage | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2010-07-01 | — | — | US | disclosed |
| EP-2170274-A1 | COMPOSITIONS, ARTICLES AND METHODS COMPRISING TSPO LIGANDS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | Technion Research and Development Foundation, Ltd. (IL) | 2010-04-07 | — | — | EP | disclosed |
| EP-2152102-A2 | COMPOSITIONS, ARTICLES AND METHODS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | Technion Research & Development Foundation Ltd. (IL) | 2010-02-17 | — | — | EP | disclosed |
| US-7271161-B2 | Platinum complexes as antitumor agents in combination with biochemical modulation | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2007-09-18 | — | — | US | disclosed |
| EP-1536864-A2 | PLATINUM COMPLEXES AS ANTITUMOR AGENTS IN COMBINATION WITH BIOCHEMICAL MODULATION | BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 2005-06-08 | — | — | EP | disclosed |
| US-20040097423-A1 | Platinum complexes as antitumor agents in combination with biochemical modulation | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2004-05-20 | — | — | US | disclosed |
| WO-2004024062-A2 | PLATINUM COMPLEXES AS ANTITUMOR AGENTS IN COMBINATION WITH BIOCHEMICAL MODULATION | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2004-03-25 | — | — | WO | disclosed |
| WO-2003000172-A2 | METHODS, PHARMACEUTICAL COMPOSITIONS, ORAL COMPOSITIONS, FILTERS AND TOBACCO PRODUCTS FOR PREVENTING OR REDUCING TOBACCO SMOKE-ASSOCIATED INJURY IN THE AERODIGESTIVE TRACT OF A SUBJECT | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2003-01-03 | — | — | WO | disclosed |
| WO-2002029416-A2 | METHOD FOR DETERMINING CHEMICAL REACTIVITY | PHARMACIA & UPJOHN COMPANY (US) | 2002-04-11 | — | — | WO | disclosed |
| EP-0674505-A1 | SYNERGISTIC COMBINATIONS OF ACTIVE SUBSTANCE FOR THE COSMETIC OR DERMATOLOGICAL CARE OF THE SKIN, HAIR AND NAILS | Beiersdorf Aktiengesellschaft (DE) | 1995-10-04 | — | — | EP | disclosed |
| WO-1994014412-A1 | SYNERGISTIC COMBINATIONS OF ACTIVE SUBSTANCE FOR THE COSMETIC OR DERMATOLOGICAL CARE OF THE SKIN, HAIR AND NAILS | BEIERSDORF AG (DE) | 1994-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097423-A1 | Platinum complexes as antitumor agents in combination with biochemical modulation | TP53, GGT1, APEX1 | FOLH1 101/4885PTGS1 305/4885GSTK1 6/4885 |
| US-20100166833-A1 | Compositions, articles and methods for preventing or reducing tobacco-associated damage | SOD1, SOD3, MGMT | FOLH1 148/4885PTGS1 577/4885GSTK1 72/4885 |
| US-20100179133-A1 | COMPOSITIONS, ARTICLES AND METHODS COMRISING TSPO LIGANDS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | TACR2, TSPO, GABRB3 | FOLH1 1597/4885PTGS1 364/4885GSTK1 437/4885 |
| US-20120012123-A1 | COMPOSITIONS, ARTICLES AND METHODS FOR PREVENTING OR REDUCING TOBACCO-ASSOCIATED DAMAGE | SOD1, SOD3, MGMT | FOLH1 148/4885PTGS1 577/4885GSTK1 72/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.